Dutch Media Outlet VPRO Becomes First in Netherlands to Deploy C2PA Digital Signatures in Editorial Workflow

In a pilot project, Dawn Technology and Media Campus NL created the open‑source verification service Verifieermij.nl, which checks C2PA provenance data embedded in digital images. The VPRO is the first Dutch media outlet to integrate this digital signature into its workflow, and the tool’s code has been released on GitHub for other organisations to test and adapt.

Italian Insurtech Mama Insurance Raises Funding Led by Fastweb+Vodafone to Expand Beyond Home Insurance

Italian insurtech Mama Insurance raised a new round of funding led by Fastweb+Vodafone, with support from Founders Factory and Vento, increasing its total capital to more than €2 million. The financing will be used to scale its AI‑native digital insurance platform beyond home insurance into other personal lines and SME products.

US Networking Giant Ciena Acquires Italian Photonics Startup PhotonPath

Italian deep‑tech startup PhotonPath, founded in 2019 as a spin‑off from Politecnico di Milano and backed by several European investors, was acquired in full by US‑listed company Ciena. The deal, whose financial terms were not disclosed, marks a new development phase for the Milan‑based photonics company, which will keep its staff and headquarters in Italy.

Dutch AgTech Startup Gravity Gardens Raises €2.6 Million to Scale Chemical-Free Seed Activation Technology

Dutch AgTech startup Gravity Gardens raised €2.6 million in a Seed round led by VP Capital, with participation from Brightlands Venture Partners, Graduate Ventures and private investors, to commercialise its dry, chemical‑free seed activation process and build industrial‑scale equipment for broader crop applications.

Italian Oncologists Call on US Biotech to Launch Compassionate-Use Program for Pancreatic Cancer Drug

Aiom is urging US biotech company Revolution Medicines to launch a compassionate‑use program for daraxonrasib, a targeted therapy that has doubled survival in a pancreatic cancer trial. While the drug received FDA approval in the United States, no similar early‑access program exists in Europe, and Revolution Medicines has not submitted a registration dossier to the European Medicines Agency. Aiom and Italian oncologists argue the drug should be provided free of charge to Italian patients pending approval, citing ethical concerns over high import costs.

Italian Startup Drita Capital Partners Launches Search Fund with €640,000 to Acquire Family-Owned SMEs

Drita Capital Partners, founded by former Polimi Graduate School of Management students Nazario Monzillo and Yll Luma, announced the creation of Italy’s first search fund. The fund raised €640,000 from a network of institutional and private investors to spend a 24‑month scouting period aimed at acquiring a high‑potential Italian family‑owned SME in sectors such as ICT, healthcare, manufacturing or food & beverage.